Literature DB >> 10608794

Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis.

G T Seah1, G M Scott, G A Rook.   

Abstract

The extent of type 2 cytokine gene expression in patients with pulmonary tuberculosis (TB) was studied by use of quantitative nested reverse-transcription polymerase chain reaction on freshly isolated peripheral blood mononuclear cells. Interleukin (IL)-4 and IL-13 mRNA expression was significantly greater in patients-median mRNA copy numbers were 1.7 and 1.1 log10 higher, respectively-than in matched tuberculin-positive control subjects. Significant correlations with radiologic extent of disease and serum IgE levels supported the biologic significance of these results. Interferon-gamma mRNA copy numbers exceeded those of type 2 cytokines but were only marginally lower in patients than in control subjects. Gene expression of an IL-4 splice variant (IL-4delta2) was bimodally distributed in both patient and control groups. Patients with greater IL-4delta2 expression also expressed more IL-4 mRNA and had more extensive disease. Type 2 cytokines are associated with immunopathologic changes in TB patients but could be a cause or consequence of disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10608794     DOI: 10.1086/315200

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  62 in total

1.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 2.  Factors affecting susceptibility and resistance to tuberculosis.

Authors:  P D Davies; J M Grange
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Cytokine polarization in miliary and pleural tuberculosis.

Authors:  Surendra K Sharma; Dipender K Mitra; Arumugam Balamurugan; Ravindra M Pandey; Narinder K Mehra
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

4.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.

Authors:  Clare R Sander; Ansar A Pathan; Natalie E R Beveridge; Ian Poulton; Angela Minassian; Nicola Alder; Johan Van Wijgerden; Adrian V S Hill; Fergus V Gleeson; Robert J O Davies; Geoffrey Pasvol; Helen McShane
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

6.  Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.

Authors:  F Abebe; T Mustafa; A H Nerland; G A Bjune
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

7.  Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Authors:  Yun-Gyoung Hur; Amelia C Crampin; Christina Chisambo; James Kanyika; Rein Houben; Richard Ndhlovu; Themba Mzembe; Maeve K Lalor; Jacky Saul; Keith Branson; Carolynne Stanley; Bagrey Ngwira; Neil French; Tom H Ottenhoff; Hazel M Dockrell; Patricia Gorak-Stolinska
Journal:  Clin Vaccine Immunol       Date:  2013-11-27

8.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

Authors:  J Dormans; M Burger; D Aguilar; R Hernandez-Pando; K Kremer; P Roholl; S M Arend; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

10.  T-cell mRNA expression in response to Mycobacterium bovis BCG vaccination and Mycobacterium bovis infection of white-tailed deer.

Authors:  Tyler C Thacker; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.